NCT04331015 (DFNA9) is a clinical trial of Pure tone audiometry in DFNA9, sponsored by Jessa Hospital.

Who is sponsoring NCT04331015?

NCT04331015 is sponsored by Jessa Hospital.

What drugs are being tested in NCT04331015?

Interventions in NCT04331015: Pure tone audiometry.

What condition does NCT04331015 study?

NCT04331015 studies DFNA9, Sensorineural Hearing Loss.

Is NCT04331015 still recruiting?

NCT04331015 is currently completed. Last updated 3 April 2020.

Last reviewed 2020-04-03 · How we verify

NCT04331015: DFNA9

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Artificial Intelligence in Diagnosis of DFNA9

Completed Last updated 3 April 2020

What this trial tests

trial testing Pure tone audiometry in DFNA9 in 111 participants. Completed in 28 March 2020.

Timeline

1 February 2020

Primary endpoint
28 March 2020

28 March 2020

Quick facts

Lead sponsor	Jessa Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	111
Start date	1 February 2020
Primary completion	28 March 2020
Estimated completion	28 March 2020
Sites	2 locations across Belgium

Drugs / interventions tested

Pure tone audiometry

Conditions studied

DFNA9 — all drugs for DFNA9 →
Sensorineural Hearing Loss — all drugs for Sensorineural Hearing Loss →

Sponsor

Jessa Hospital

Who can join

18 and older, any sex, with DFNA9 or Sensorineural Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the positive predictive value of Audiogene v.4.0 open source online machine learning tool in accurately predicting DFNA9 (DeaFNess autosomal dominant ninth) as top 3 gene loci in a large series of genetically confirmed c.151C\>T,p.Pro51Ser (p.P51S) variant carriers in COCH (coagulation factor C Homology).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for DFNA9

Currently open trials in the same condition.

NCT04070937 — Correlation of Radiological Lesions With Vestibular Function in Patients With Bilateral Vestibulopathy · recruiting
NCT03716908 — Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients · recruiting

Other Jessa Hospital trials

Trials by the same sponsor.

NCT07483775 — Feasibility and Health-economic Evaluation of Remote Clinical Monitoring Enabling Same-day Discharge After Bariatric Sur · NA · not yet recruiting
NCT06881602 — Remote Clinical Monitoring After Robotic Distal Pancreatectomy · NA · not yet recruiting
NCT07010055 — Using Digital Health in a Postoperative Setting After Major Surgery: Semi-structured Interview Study · NA · not yet recruiting
NCT07010081 — Using Digital Health in a Postoperative Setting After Major Surgery: Survey Study · NA · recruiting
NCT07482267 — Evaluation of Patients Suffering From Polytrauma Admitted to the ICU · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04331015 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jessa Hospital
Last refreshed: 3 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04331015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing